Evidence map›Paper›PMID 41772180›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Hedonic hotspot in rat olfactory tubercle: map for mu-opioid, orexin, and muscimol enhancement of sucrose 'liking'.

Koshi Murata, Kent C Berridge

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Koshi MurataDepartment of Psychology, University of Michigan, Ann Arbor, MI, USA. kmurata@g.u-fukui.ac.jp.ORCID http://orcid.org/0000-0002-6425-3053
Kent C BerridgeDepartment of Psychology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-6031-2626

Funding

Public Outreach and Education CoreP50NS091856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAUER, WILLIAM T. · 2014 to 2019
$10.1M
Affective neuroscience of taste reactivityR01MH063649 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERRIDGE, KENT C. · 2002 to 2024
$7.8M
Cue-triggered Reward SeekingR01DA015188 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERRIDGE, KENT C. · 2003 to 2021
$4.9M
MEXT | Japan Society for the Promotion of Science (JSPS) 24K02131MEXT | Japan Society for the Promotion of Science (JSPS) JP17KK0190MEXT | Japan Society for the Promotion of Science (JSPS) JP20H05955MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05817MEXT | Japan Society for the Promotion of Science (JSPS) JP21K06440NIDA NIH HHS R01 DA015188NIMH NIH HHS R01 MH063649U.S. Department of Health & Human Services | National Institutes of Health (NIH) DA015188U.S. Department of Health & Human Services | National Institutes of Health (NIH) MH063649U.S. Department of Health & Human Services | National Institutes of Health (NIH) P50NS091856
6 · The paper itself

Abstract

Pleasure plays a crucial role in positive reinforcement and motivation. Brain regions able to amplify positive hedonic reactions to sweetness, known as 'hedonic hotspots', are distributed within the mesocorticolimbic reward systems. The olfactory tubercle (OT), a part of the ventral striatum that receives olfactory input, contains distinct functional domains: the anteromedial domain mediates approach motivation toward odors associated with food, whereas the lateral domain mediates avoidance motivation away from odors associated with danger. However, it has remained unclear whether the OT modulates hedonic reactions to pleasant sensations. In this study, we made pharmacological microinjections in OT of rats to examine whether these OT subregions can modulate hedonic reactions, as assessed by the taste reactivity test. Sweet oral infusions of sucrose solution were delivered into the mouth via an intraoral cannula, and the rats' orofacial and somatic hedonic reactions were recorded and analyzed. We compared three pharmacological agents: mu-opioid receptor agonist DAMGO, orexin-A peptide, and GABA

Indexed as

Intracellular Signaling Peptides and ProteinsMuscimolNeuropeptidesOlfactory TubercleReceptors, Opioid, muSucroseAnimalsBrain MappingEnkephalin, Ala(2)-MePhe(4)-Gly(5)-GABA-A Receptor AgonistsMaleMicroinjectionsOrexinsRatsRats, Sprague-DawleyEnkephalin, Ala(2)-MePhe(4)-Gly(5)-GABA-A Receptor AgonistsIntracellular Signaling Peptides and ProteinsMuscimolNeuropeptidesOrexinsReceptors, Opioid, muSucrose

Identifiers

PMID41772180
PMCPMC13084741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.